Steven Reinberg/HealthDay: Alzheimer's Research Brings Progress, Setbacks:
In one of two studies in the July 19 issue of The Lancet, an older drug called dimebon significantly improved Alzheimer's symptoms. But in a second report, a once-promising vaccine failed to prevent the progression of Alzheimer's -- even though it cleared dementia-linked amyloid plaques in the brain.
Seems the research in this area is advancing at a decent clip. Seems the research in this area is advancing at a decent clip.
:: :: ::
© Image @ StarFleet Library
Well at ther very least we could strive to be
Number 48 instead of 49 when compared with the rest of the world.